Literature DB >> 28573534

The clinical characteristics and prognosis of acute zonal occult outer retinopathy.

Shancheng Si1, Wei Song2, Yifan Song3, Yuntao Hu4,5.   

Abstract

PURPOSE: This prospective observational case series study aimed to observe the clinical characteristics of acute zonal occult outer retinopathy (AZOOR) and its prognosis in Chinese Han patients.
METHODS: Six eyes of 5 female patients diagnosed with AZOOR were followed up for 4 months to observe the natural disease course. All enrolled subjects underwent a series of ocular examinations at the onset and each return visit, including best corrected visual acuity (BCVA), split lamp microscopy, fundus photography, optical coherence tomography (OCT), perimetry, multifocal electroretinogram and fundus fluorescein angiography.
RESULTS: Over the follow-up, all enrolled patients recovered on BCVA, perimetry and OCT in different degrees. Among them, one patient recovered completely since the ocular examination results returned to normal.
CONCLUSION: AZOOR is a rare ocular disorder in Chinese population. Our results demonstrated that visual functions of enrolled patients significantly improved spontaneously, indicating that Chinese female Han patients with AZOOR have good visual outcomes during the follow-up period without any specific managements.

Entities:  

Keywords:  Acute zonal occult outer retinopathy; Fundus fluorescein angiography; Goldmann perimetry; Multifocal electroretinogram; Optical coherence tomography

Mesh:

Year:  2017        PMID: 28573534     DOI: 10.1007/s10792-017-0580-9

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  22 in total

1.  Acute zonal occult outer retinopathy: Donders Lecture: The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992. 1993.

Authors:  J Donald M Gass
Journal:  Retina       Date:  2003-12       Impact factor: 4.256

Review 2.  Acute zonal occult outer retinopathy.

Authors:  Dinelli M Monson; Justine R Smith
Journal:  Surv Ophthalmol       Date:  2010-11-05       Impact factor: 6.048

3.  High-definition optical coherence tomography findings in acute idiopathic blind spot enlargement (AIBSE) syndrome.

Authors:  Niloofar Piri; Henry J Kaplan; Douglas K Sigford; Tongalp H Tezel
Journal:  Ocul Immunol Inflamm       Date:  2014-01-16       Impact factor: 3.070

4.  Pattern of retinal dysfunction in acute zonal occult outer retinopathy.

Authors:  S G Jacobson; D S Morales; X K Sun; W J Feuer; A V Cideciyan; J D Gass; A H Milam
Journal:  Ophthalmology       Date:  1995-08       Impact factor: 12.079

5.  Fundus autofluorescence and optical coherence tomographic findings in acute zonal occult outer retinopathy.

Authors:  Takamitsu Fujiwara; Yutaka Imamura; Vincent J Giovinazzo; Richard F Spaide
Journal:  Retina       Date:  2010-09       Impact factor: 4.256

6.  Acute zonal occult outer retinopathy. Donders Lecture: The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992.

Authors:  J D Gass
Journal:  J Clin Neuroophthalmol       Date:  1993-06

7.  Clinical characteristics of acute zonal occult outer retinopathy in Chinese patients.

Authors:  Zong-Ming Song; Yan-Juan Sheng; Qing-Shan Chen; An-Quan Xue; Bin Lin; Ying-Zi Li; Xiao-Ying Fu
Journal:  Ophthalmologica       Date:  2008-05-22       Impact factor: 3.250

8.  Acute zonal occult outer retinopathy in patients with multiple evanescent white dot syndrome.

Authors:  Howard F Fine; Richard F Spaide; Edwin H Ryan; Yoko Matsumoto; Lawrence A Yannuzzi
Journal:  Arch Ophthalmol       Date:  2009-01

9.  Multifocal electroretinogram indicates visual field loss in acute zonal occult outer retinopathy.

Authors:  M Arai; N Nao-i; A Sawada; T Hayashida
Journal:  Am J Ophthalmol       Date:  1998-09       Impact factor: 5.258

10.  Changes in outer retinal microstructures during six month period in eyes with acute zonal occult outer retinopathy-complex.

Authors:  Yoshitsugu Matsui; Hisashi Matsubara; Shinji Ueno; Yasuki Ito; Hiroko Terasaki; Mineo Kondo
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.